92 related articles for article (PubMed ID: 23127971)
21. Distribution and volume of extrauterine disease in uterine serous carcinoma: is minimally invasive surgery a suitable approach?
Ayeni TA; AlHilli MM; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Int J Gynecol Cancer; 2015 Jan; 25(1):87-91. PubMed ID: 25474625
[TBL] [Abstract][Full Text] [Related]
22. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
[TBL] [Abstract][Full Text] [Related]
23. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394
[TBL] [Abstract][Full Text] [Related]
24. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
25. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
[TBL] [Abstract][Full Text] [Related]
26. Role of surgical staging and adjuvant treatment in uterine serous carcinoma.
Frey MK; Bashir S; Ward NM; Hensel KJ; Caputo TA; Holcomb KM; Baergen R; Gupta D
Eur J Gynaecol Oncol; 2013; 34(5):453-6. PubMed ID: 24475582
[TBL] [Abstract][Full Text] [Related]
27. Malignant Endometrial Polyps in Uterine Serous Carcinoma: The Prognostic Value of Polyp Size and Lymphovascular Invasion.
Ouyang C; Frimer M; Hou LY; Wang Y; Goldberg GL; Hou JY
Int J Gynecol Cancer; 2018 Mar; 28(3):524-528. PubMed ID: 29420362
[TBL] [Abstract][Full Text] [Related]
28. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG
Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465
[TBL] [Abstract][Full Text] [Related]
29. The role of optimal debulking in advanced stage serous carcinoma of the uterus.
Moller KA; Gehrig PA; Van Le L; Secord AA; Schorge J
Gynecol Oncol; 2004 Jul; 94(1):170-4. PubMed ID: 15262137
[TBL] [Abstract][Full Text] [Related]
30. The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma.
Bishop EA; Lengyel ER; Yamada SD; Montag A; Temkin SM
Gynecol Oncol; 2011 Apr; 121(1):218-23. PubMed ID: 21168200
[TBL] [Abstract][Full Text] [Related]
31. Trends in Survival of Patients With Uterine Serous Carcinoma From 1988 to 2011: A Population-Based Study.
Mahdi H; Han X; Moulton L; Vargas R
Int J Gynecol Cancer; 2017 Jul; 27(6):1155-1164. PubMed ID: 28562471
[TBL] [Abstract][Full Text] [Related]
32. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
33. Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomen.
Lee LJ; Demaria R; Berkowitz R; Matulonis U; Viswanathan AN
Gynecol Oncol; 2014 Jan; 132(1):65-9. PubMed ID: 24211401
[TBL] [Abstract][Full Text] [Related]
34. A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: is there a difference?
Hou JY; McAndrew TC; Goldberg GL; Whitney K; Shahabi S
Reprod Sci; 2014 Apr; 21(4):532-7. PubMed ID: 24023030
[TBL] [Abstract][Full Text] [Related]
35. A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy.
Tran LKH; Tran PMH; Mysona DP; Purohit SB; Myers E; Lee WS; Dun B; Xu D; Liu H; Hopkins D; Nechtman J; Scelsi CL; Mittal PK; Kleven D; Wallbillich JJ; Rungruang B; Ghamande S; She JX
Gynecol Oncol; 2020 May; 157(2):340-347. PubMed ID: 32067813
[TBL] [Abstract][Full Text] [Related]
36. Oncologic safety of laparoscopic surgery for women with apparent early-stage uterine serous carcinoma: A multi-institutional retrospective cohort study.
Xu Y; Shen J; Zhang Q; He Y; Chen C; Tian Y
Int J Gynaecol Obstet; 2022 Jul; 158(1):162-171. PubMed ID: 34561857
[TBL] [Abstract][Full Text] [Related]
37. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
[TBL] [Abstract][Full Text] [Related]
38. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Tolcher MC; Swisher EM; Medeiros F; Lima JF; Hilderbrand JL; Donovan JL; Garcia RL; Cliby WA; Dowdy SC
Int J Gynecol Pathol; 2015 Jan; 34(1):57-64. PubMed ID: 25473754
[TBL] [Abstract][Full Text] [Related]
39. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
40. Outcomes in surgical stage I uterine papillary serous carcinoma.
Havrilesky LJ; Secord AA; Bae-Jump V; Ayeni T; Calingaert B; Clarke-Pearson DL; Berchuck A; Gehrig PA
Gynecol Oncol; 2007 Jun; 105(3):677-82. PubMed ID: 17355889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
